From the lab to the leadership team, breakthrough science demands collaboration. To further our mission to eliminate cancer and related diseases, we partner with top-caliber institutions, companies and philanthropic organizations.
As an academic, teaching, research and patient-treatment organization, Fred Hutch works with other institutions worldwide to develop lifesaving, leading-edge therapies. These therapies and the highest-quality care are made available to patients from around the world through our patient-care environment.
We also collaborate with leading technology companies on game-changing data science projects. One such project uses novel patient-engagement tools that employ biosensors and mobile apps, artificial intelligence and computer vision applications in radiology. Another project uses natural-language processing tools to reduce the time it takes to annotate patient records.
Institutional Partners
Cancer Consortium
Cancer Information Service
Cancer Consortium
The Fred Hutch/University of Washington/Seattle Children's Cancer Consortium was formed in 2002 to enhance and accelerate cancer research. It combines the strengths of three independent powerhouses: Fred Hutch, University of Washington and Seattle Children’s. The consortium brings together more than 600 faculty with research interests in basic, clinical and public health sciences.
Collaborations
Brotman Baty Institute for Precision Medicine
Brotman Baty Institute for Precision Medicine
This UW Medicine, Fred Hutch and Seattle Children’s collaboration uses genetic or molecular profiling to create precision treatments for patients.
Allen Institute for Immunology
Allen Institute for Immunology
We work with the Allen Institute to chart the immune system using big data and emerging technologies to reveal how immunity goes astray in cancer.